
Rapamycin: Smart Drug or Risky Bet?
Rapamycin is an FDA-approved immune-suppressing medication used to prevent transplant rejection. In mice it extends lifespan, which has fueled a wave of off-label use for longevity. In humans, the evidence is thinner, the side effects are real (mouth sores, higher cholesterol, blunted muscle growth, and infections), and we use it cautiously, if at all.
Rapamycin: The Signal and the Noise
The Most Overhyped Molecule in Longevity Medicine?
Why Mouse Data Does Not Always Translate to Humans
The Interventions Testing Program (ITP) showed that rapamycin extends life in mice by about 28%. That part is real. The translation to humans gets harder for a few reasons.- Sterile environment. Lab mice are kept in pathogen-free housing. They do not ride SEPTA. They do not have kids in daycare. Suppressing their immune system does not get them sick because they are not exposed to anything.
- Different biology. Mice mostly die of cancer (lymphoma). Rapamycin suppresses cancer well. Humans mostly die of heart disease and neurodegeneration. The mechanism of death is different.
Let's get healthier
Get Dr. Ash's health checklist.
Bi-weekly clinical insights on the markers that matter most - what to track, what to ask your doctor, and what 'normal' actually means. Trusted by 1,248+ Philadelphians.
Evidence-informed clinical signal from our practice
Why Do Patients Stop Taking Rapamycin?
In our clinical experience, a significant share of patients who start rapamycin stop within six months. Not because it "does not work," but because the side effects are real and the benefits are invisible. When you take a statin, your cholesterol drops. You see the number change. When you take rapamycin, you feel nothing, or worse, you feel sick.The "Big Three" Reasons People Stop
- Mouth sores (aphthous ulcers). This is the most common side effect. Painful, recurring sores that make eating hard. They are a sign of mucosal immune suppression.
- Worsening cholesterol. Rapamycin often raises LDL cholesterol and triglycerides. You take a drug to live longer and end up needing another drug to control your heart disease risk.
- Lingering infections. "Dr. Ash, I have had a cold for six weeks." We hear this often. Rapamycin blunts the immune response. Minor infections drag on. Bacterial infections can become more serious.
What Are the Risks of Inhibiting mTOR Long-Term?
Fishtown Medicine
A 90-minute conversation with Dr. Ash. A written plan you can actually follow.
- The good. It can slow cancer cell growth and increase autophagy (the process by which cells clear out damaged proteins).
- The bad. It also slows muscle growth and wound healing. Sarcopenia (the loss of muscle with age) is one of the strongest predictors of frailty and death after 60. Suppressing muscle growth in older adults is a real concern.
Guidance from the Clinic

Why we are skeptical. We have seen the peak hype cycle before (resveratrol, metformin, NAD+). Rapamycin is currently at the top of that curve. In 5 years we expect the excitement to settle into a narrow, careful use case.> "But Dr. Ash, I read that pulse dosing is safe." My answer: safer than daily dosing, maybe. Safe in the absolute sense, no. Even with weekly dosing, we see side effects. Biology rarely offers a free lunch. If you turn down the immune dial, you open the door to other problems.
Our Strategy: Proceed With Caution
If you are determined to try rapamycin, we will support you, but we will not cheerlead.- Exclusion criteria. If you have low muscle mass, a history of chronic infections, or are trying to build strength, rapamycin is a hard no.
- Safety monitoring. We require monthly labs for the first three months to watch lipids, glucose, and infection markers.
- The exit ramp. We set a low threshold for stopping. A mouth sore means pause. A real infection means stop.
- Cycling. We use significant washout periods (months off the drug) to let your body recover its anabolic (growth) capacity.
Scientific References
- Dillman AM, et al. Rapamycin: minimal benefits, maximum risks? GeroScience. 2023.
- Bischof E, et al. Clinical challenges of rapamycin in longevity medicine. Lancet Healthy Longev. 2021.
- Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009.
- Mannick JB, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018.
- Kraig E, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort. Exp Gerontol. 2018.
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Still have a question?
He answers personally. Usually within a few hours.
Related Intelligence

Longevity Strategies | Fishtown Medicine
Strategies to extend your healthspan and optimize lifespan in Philadelphia.

Biological Age Testing: Truth vs. Marketing
You have two ages: chronological and biological. See why epigenetic methylation clocks are the gold standard for measuring how fast you are aging.

The Metabolic Reset: GLP-1 Agonists Beyond Weight Loss
Why semaglutide and tirzepatide are more than diet drugs. They lower inflammation, dampen addiction circuits, and protect the heart.
Talk it through with Dr. Ash.
If anything you read here raised a question, this is a free 20-minute Warm Invitation Call. Pick a time and we’ll work through it together.
Loading scheduler...
Having trouble with the scheduler? Book directly on Dr. Ash’s calendar
